donate
ourwork

News & Events

View All News & Events
 
  • Header 03

Oxford Declaration

AfrOx, in partnership with Cardiff University, held an international meeting at St. Catherine's College, Oxford in March 2009 to set down a strategy for preventing cervical cancer in Africa and issue an international call for action in combating the disease.

At the end of the meeting, the delegates signed the Oxford Declaration committing, for the first time, to global cooperation to eradicate cervical cancer in Africa.
 

PREVENTION OF CERVICAL CANCER IN AFRICA:
A CALL TO ACTION
THE OXFORD DECLARATION, 27 March 2009

Every 10 minutes, a woman in Africa dies from cervical cancer, despite the fact that almost every case is preventable through a programme of screening, treatment and vaccination against the Human Papilloma Virus (HPV).

Participants (African First Ladies, African health ministers, clinicians, activists and representatives of NGOs and pharmaceutical industry) attending this convention, organised by Afrox, have unanimously agreed to the following three resolutions:

  1. We call upon all African governments to recognise and acknowledge the magnitude of the problem of cervical cancer in Africa and the need for immediate, coordinated international action.
  2. We will work with African Governments, NGOs and other international partners through consensus to implement effective cervical cancer screening including treatment programmes, taking into account the latest technology and ensuring equity of access for all women and girls.
  3. We will galvanise African Governments, the GAVI Alliance, the pharmaceutical industry, and other international partners to utilise newly emerging tools to deliver an effective and affordable programme of HPV vaccination to the nations of Sub-Saharan Africa and support research which will advance knowledge in this field.


We unanimously agree that implementation of this declaration requires immediate, vigorous and collective action.

All attendees at the AfrOx HPV Convention hereby commit their support to this Declaration:
 

Her Excellency Dr

Turai Umaru

Yar’Adua

First Lady of Federal Republic of Nigeria

Her Excellency, Mrs

Janet

Museveni

First Lady of Republic of Uganda and member of Parliament

Professor

Isaac

Adewole

College of Medicine, University of Ibadan, Nigeria

Ms

Rebecca

Affolder

GAVI Alliance, Switzerland

Dr

Raghib

Ali

University of Oxford, UK

Sir

John

Arbuthnott

University of Oxford, UK

Miss

Suzanne

Ashman

 

University Hospital of Wales, UK

Mr

Lekan

Asuni

GSK Pharmaceuticals, Anglophone West Africa, Nigeria

Mr

Hassan

Azadeh

Foundation for Research on Women's Health, Productivity and the Environment, The Gambia

Dr

Joan

Benson

Merck & Company Inc, USA

Dr

William

Bosu

Disease Control and Prevention Dept, Ghana

Mrs

Carolyn

Burgess

Language is Everything, UK

Dr

Mark

Clanton

American Cancer Society, USA

Mrs

Ramou

Cole-Ceesay

Dept of State for Health, The Gambia

Mr

Mark

Connolly

Global Market Access Solutions, Switzerland

Professor

Heather

Cubie

Royal Infirmary of Edinburgh, UK

Dr

Myfanwy

Davies

University of Cardiff, UK

Dr

Philip

Davies

ECCA, France

Ms

Maria Stella

De Sabata

Fondo Anglesio Moroni, Italy

Professor

Francis Abayomi

Durosinmi-Etti

National Consultative Committee on Cancer Control, Nigeria

Prof Dr

Ahmed

Elzawawy

 ICEDOC, Egypt

Ms

Julia

Emanuel

 

Professor

Alison

Fiander

Cardiff University, UK

Dr

Kenneth

Fleming

University of Oxford, UK

Dr

Silvia

Franceschi

IARC, France

Dr

Felix

Frempong

Ghanaian Cancer Society, Ghana

Dr

Hadiza

Galadanci

Aminu Kano Teaching Hospital, Nigeria

Prof

Winald

Gerritsen

VUmc Cancer Centre, The Netherlands

Dr

Joe

Harford

National Cancer Institute, USA

Dr

Danielle

Heideman

VU University Medical Centre, The Netherlands

Dr

Luc

Hessel

Sanofi Pasteur MSD, France

Dr

Mariatou

Jallow

Ministry of Health, The Gambia

Dr

Mark

Jit

University of Birmingham, UK

Miss

Shoned

Jones

University of Cardiff, UK

Miss

Victoria Isabelle

Kay

UICC, Switzerland

Miss

Susan

Keese

Qiagen UK Ltd, UK

Prof 

Sean

Kehoe

The Womens Centre, Oxford Radcliffe NHS Trust,  UK

Prof

David

Kerr

SIDRA, Qatar and University of Oxford, UK

Prof

Henry

Kitchener

University of Manchester, UK

Dr

Nicholas

Kitchin

Sanofi Pasteur MSD, UK

Dr

Mark

Krul

Aglaia Oncology Fund, The Netherlands

Dr

Jeremy

Lauer

WHO, Switzerland

Prof

Gerhard

Lindeque

University of Pretoria, South Africa

Miss

Isabel

Litwin-Davies

University of London, UK

Dr

Julian

Lob-Levyt

GAVI Alliance, Switzerland

Mr

Attahirli

Maccido

Federal Ministry of Women Affairs & Social Development, Nigeria

Dr

Helen

McShane

University of Oxford, UK

Dr

Rachel

Midgley

University of Oxford, UK

Professor

Florence

Mirembe

Makerere University, Uganda

Dr

Jo

Morrison

University of Oxford, UK

Dr

Emmanuel

Mugisha

PATH, Uganda

Dr

Twalib

Ngoma

AORTIC, Tanzania

Hon

Sarah

Nyombi

Parliament of Uganda, Uganda

Lady

Theresa Nkeoma

Nwosu

Princess Nikky Breast Cancer Foundation, Nigeria

Professor

Ifeoma

Okoye

Dept of Radiation Medicine, College of Medicine, University of Nigeria, Nigeria

Princess

Nikky

Onyeri

Princess Nikky Breast Cancer Foundation, Nigeria

Dr

Patience

Osinubi

Federal Ministry of Health, Nigeria

Professor

Julian

Peto

London School of Hygiene & Tropical Medicine and the Institute of Cancer Research, UK

Prof Sir

Richard

Peto

University of Oxford, UK

Mr

Tom

Peto

London School of Hygiene & Tropical Medicine and the Institute of Cancer Research, UK

Mr

Doug

Pyle

American Society of Clinical Oncology, USA

Dr

Anne

Reeler

Axios International, France

Mr

Dave

Roberts

Morgan Roberts Ltd, UK

Ms

Anne

Ruglys

Sanofi Pasteur MSD, UK

Dr

Joseph

Saba

Axios International, France

Rev Fr

Victor

Sackey

Cancer Society of Ghana, Ghana

Miss

Panayota

Sakulias

GSK, UK

Dr

Rengaswamy

Sankaranarayanan

IARC, France

Professor

Peter

Snijders

VU University Medical Centre, The Netherlands

Professor

Margaret

Stanley

University of Cambridge, UK

Hon Minister

Salamatu

Suleiman

Federal Ministry of Women Affairs & Social Development, Nigeria

Dr

Kate

Taylor

GSK Biologicals, Belgium

Dr

Julie

Torode

International Union Against Cancer, Switzerland

Dr

Amanda

Tristram

Cardiff University, UK

Dr

Vivien

Tsu

PATH, USA

Dr

Deborah

Watson-Jones

London School of Hygiene and Tropical Medicine, UK

Professor

Edwin

Wiredu

University of Ghana, Ghana

Mr

Scott

Wittet

PATH, USA